These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 26389567)

  • 21. Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy.
    Polsky S; Giordano D; Voelmle MK; Garcetti R; Garg SK
    Postgrad Med; 2016 May; 128(4):418-26. PubMed ID: 26924774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Numerical and clinical precision of continuous glucose monitoring in Colombian patients treated with insulin infusion pump with automated suspension in hypoglycemia.
    Gómez AM; Marín Sánchez A; Muñoz OM; Colón Peña CA
    Endocrinol Nutr; 2015 Dec; 62(10):485-92. PubMed ID: 26531841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Automated insulin pump suspension for hypoglycaemia mitigation: development, implementation and implications.
    Davis T; Salahi A; Welsh JB; Bailey TS
    Diabetes Obes Metab; 2015 Dec; 17(12):1126-32. PubMed ID: 26179879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes.
    Haidar A; Rabasa-Lhoret R; Legault L; Lovblom LE; Rakheja R; Messier V; D'Aoust É; Falappa CM; Justice T; Orszag A; Tschirhart H; Dallaire M; Ladouceur M; Perkins BA
    J Clin Endocrinol Metab; 2016 Jan; 101(1):214-23. PubMed ID: 26523526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
    Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K
    Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificial Pancreas Project at Cambridge 2013.
    Hovorka R
    Diabet Med; 2015 Aug; 32(8):987-92. PubMed ID: 25819473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Single-Site Device for Conjoined Glucose Sensing and Insulin Infusion: Performance Evaluation in Diabetes Patients During Home-Use.
    Tschaikner M; Powell K; Jungklaus M; Fritz M; Ellmerer M; Hovorka R; Lane S; Pieber TR; Regittnig W
    IEEE Trans Biomed Eng; 2020 Jan; 67(1):323-332. PubMed ID: 31251175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions.
    Grosman B; Ilany J; Roy A; Kurtz N; Wu D; Parikh N; Voskanyan G; Konvalina N; Mylonas C; Gottlieb R; Kaufman F; Cohen O
    J Diabetes Sci Technol; 2016 May; 10(3):708-13. PubMed ID: 26880389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging Technologies for Diabetes Care.
    Bailey TS; Walsh J; Stone JY
    Diabetes Technol Ther; 2018 Jun; 20(S2):S278-S284. PubMed ID: 29916738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Technology on Current Diabetes Management.
    Garvey K; Wolfsdorf JI
    Pediatr Clin North Am; 2015 Aug; 62(4):873-88. PubMed ID: 26210622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.
    Steineck I; Ranjan A; Nørgaard K; Schmidt S
    J Diabetes Sci Technol; 2017 Jan; 11(1):50-58. PubMed ID: 28264173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Who needs an artificial pancreas? (？).
    Winikoff J; Drexler A
    J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Artificial Pancreas and Type 1 Diabetes.
    Nwokolo M; Hovorka R
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1614-1623. PubMed ID: 36734145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia.
    Ward WK; Castle JR; El Youssef J
    J Diabetes Sci Technol; 2011 Nov; 5(6):1373-80. PubMed ID: 22226254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical options for glycaemic control in Type 1 diabetes.
    Yeung KTD; Reddy M; Purkayastha S
    Diabet Med; 2019 Apr; 36(4):414-423. PubMed ID: 30575115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moving Toward a Unified Platform for Insulin Delivery and Sensing of Inputs Relevant to an Artificial Pancreas.
    Graf A; McAuley SA; Sims C; Ulloa J; Jenkins AJ; Voskanyan G; O'Neal DN
    J Diabetes Sci Technol; 2017 Mar; 11(2):308-314. PubMed ID: 28264192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New and Emerging Technologies in Type 1 Diabetes.
    Sherwood JS; Russell SJ; Putman MS
    Endocrinol Metab Clin North Am; 2020 Dec; 49(4):667-678. PubMed ID: 33153673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes.
    Lal RA; Ekhlaspour L; Hood K; Buckingham B
    Endocr Rev; 2019 Dec; 40(6):1521-1546. PubMed ID: 31276160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
    Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging diabetes therapies and technologies.
    Moser EG; Morris AA; Garg SK
    Diabetes Res Clin Pract; 2012 Jul; 97(1):16-26. PubMed ID: 22381908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.